Skip to main content

Advocating for Patients

AAFA Urges Inclusion of Patient Voice in Analysis of Costly New Asthma Drugs

Biologics are a new class of drugs that fight disease at the source . Instead of attacking symptoms, these drugs target diseases like asthma at a molecular level. These newer types of drugs are more expensive than older medicines. That is prompting public discussion on how to pay for them. The cost of caring for patients with the most severe forms of asthma represents a majority of asthma healthcare spending. In addition, asthma is a leading cause of missed time from work and school. Last...

AAFA Brings Perspective of Asthma, Allergy Patients to FDA

What is it like to have food allergies, asthma, or nasal allergies? What do patients need and want from their treatments? How can we improve allergy care? The chief executive officer of the Asthma and Allergy Foundation of America spoke about these issues at a recent FDA advisory committee meeting. Dr. Cary Sennett spoke to the Allergenic Products Committee about the everyday challenges of life with food allergies, asthma and other allergies. Dr. Sennett attended the meeting to represent...

Sign the Petition to Save Patient Access to Allergy Shots

Proposed regulations introduced by the United States Pharmacopeia (USP) could dramatically limit patient access to allergen immunotherapy (allergy shots). If these new regulations go into effect, allergists would unlikely be able to continue to mix allergen extracts for their patients. The result may limit timelines of allergy shot treatment. The insurance coverage of this treatment may also be restricted. What can I do to prevent these regulations from going into effect? The American...

An Important Voice for People with Asthma and Allergies

Patients should have access to new, life-saving and life-enhancing treatments for asthma and allergies. We are proud to announce: AAFA’s CEO, Dr. Cary Sennett, will be advocating on your behalf to state insurance commissioners. The National Association of Insurance Commissioners is the professional association for the regulators within each U.S. state and territory who establish and monitor the standards for healthcare insurance programs. They chose Dr. Sennett to represent the...

New Law in New Jersey Allows Access to Epinephrine in Public Places

Good news, New Jersey! Governor Christie has signed a bill into law expanding access to epinephrine auto-injectors in public places. What does this mean for you? Under the law, a person who has completed a training program will be allowed to give epinephrine to anyone experiencing a severe allergic reaction, or anaphylaxis . Certain public places and businesses (such as restaurants, amusement parks, theaters, camps, etc.) will be allowed to have auto-injectors available for allergy...

NYC Taking Steps to Promote Healthy Housing

The New York City Council is considering the Asthma-Free Housing Act of 2015 We know the environment can play a strong role in our health. But for patients with chronic conditions like asthma, a healthy indoor setting is critical. Indoor health hazards can all be asthma triggers . These hazards include mold, dust and pests (cockroaches, dust mites). Healthy indoor settings are a vital part of managing and controlling asthma. In large urban cities, older buildings and housing issues can often...

Congress May Add Sesame to the Top Food Allergens List

Congress has introduced important legislation to improve the way manufacturers label food allergens! The  Food Labeling Modernization Act of 2015 (HR 4061)  would also add sesame to the list of major food allergens. Currently, only eight allergens - milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soy - must be listed on food labels. Sesame seeds and oil are used as ingredients in many common foods, but are often vaguely labeled as "spices" or "natural seasoning". Adding...

 
Post
×
×
×
×